{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:07:45Z","timestamp":1793070465743,"version":"4.5.0"},"reference-count":35,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Myasthenia gravis (MG) and idiopathic inflammatory myopathy (IIM) are autoimmune diseases that affect the musculoskeletal system. The association of the two diseases is rare. Their management is different, so it is important to recognize the concomitant presentation. Methods: In this cross-sectional study, we study the presence of CK elevation, myositis-specific and myositis-associated antibodies (MSA\/MAA), and vitamin D levels in a cohort of 101 MG patients. Electromyography, limb magnetic resonance imaging (MRI), and, in some cases, muscle biopsy were performed when IIM was suspected. We reviewed the patients\u2019 medical records to access the results of these tests if they had been performed previously. Results: CK elevation was detected in 10 patients (9.9%). We identified one case of anti-Jo-1 antibody-positive polymyositis and two cases of possible myositis. MSA\/MAA antibodies were not found in the patients with high CK levels, except for the one with anti-Jo-1-positive IIM. One patient with elevated CK levels had an overlapping muscular dystrophy. MSA\/MAA antibodies were detected in 19 patients (18.8%). A total of 37% had high-titer antibodies and concomitant systemic autoimmune diseases, while 63% had low-titer antibodies, most of whom had no systemic autoimmune disease. Low serum vitamin D levels were found in 67.3% of patients. Comparison of myasthenia gravis composite (MGC) scores between patients with low and normal vitamin D levels did not show a statistically significant difference. Conclusions: Our results may raise awareness among neuromuscular specialists caring for MG patients of the possibility of associated myositis or other neuromuscular diseases and the need to assess vitamin D levels. Although deficiency was frequent, its impact on MG severity remains unclear, necessitating further investigation into its immunological relevance.<\/jats:p>","DOI":"10.3390\/jcm14072449","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:36:45Z","timestamp":1743737805000},"page":"2449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of Elevated CK Levels, Myositis-Specific and Myositis-Associated Antibodies, Myositis, and Other Neuromuscular Diseases in Myasthenia Gravis Patients\u2014Experience from an Eastern European Tertiary Center"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9737-8217","authenticated-orcid":false,"given":"M\u00e1rk","family":"Koz\u00e1k","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, University of Debrecen, 22 M\u00f3ricz Zsigmond krt., 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurology, Szent Margit Budapest Hospital, 132 B\u00e9csi \u00fat, 1032 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Nagy-Vince","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, 22 M\u00f3ricz Zsigmond krt., 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-3653","authenticated-orcid":false,"given":"Attila","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, 22 M\u00f3ricz Zsigmond krt., 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-5767","authenticated-orcid":false,"given":"Judit","family":"Bocz\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, University of Debrecen, 22 M\u00f3ricz Zsigmond krt., 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.semarthrit.2013.12.005","article-title":"The Co-Existence of Myasthenia Gravis in Patients with Myositis: A Case Series","volume":"43","author":"Paik","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-510X(02)00200-9","article-title":"The Role of Antibodies in Myasthenia Gravis","volume":"202","author":"Stassen","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102498","DOI":"10.1016\/j.autrev.2020.102498","article-title":"Muscle Involvement in Myasthenia Gravis: Expanding the Clinical Spectrum of Myasthenia-Myositis Association from a Large Cohort of Patients","volume":"19","author":"Garibaldi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2017.04.009","article-title":"Inflammatory Myopathy Associated with Myasthenia Gravis with and without Thymic Pathology: Report of Four Cases and Literature Review","volume":"16","author":"Santos","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yu, Z., Cheng, H., Liang, Y., Ding, T., Yan, C., Gao, C., and Wen, H. (2021). Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients with Idiopathic Inflammatory Myopathy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.642070"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.semarthrit.2018.05.004","article-title":"Concurrent Inflammatory Myopathy and Myasthenia Gravis with or without Thymic Pathology: A Case Series and Literature Review","volume":"48","author":"Huang","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.nmd.2007.05.010","article-title":"Muscle Lymphocytic Infiltrates in Thymoma-Associated Myasthenia Gravis Are Phenotypically Different from Those in Polymyositis","volume":"17","author":"Zamecnik","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in Patients with MG: Characteristics and Long-Term Outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D Deficiency in Patients with Myasthenia Gravis and Improvement of Fatigue after Supplementation of Vitamin D 3: A Pilot Study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/annrheumdis-2012-201849","article-title":"Low Serum Levels of Vitamin D in Idiopathic Inflammatory Myopathies","volume":"72","author":"Azali","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/php.13432","article-title":"Low Vitamin D Serum Levels in a Cohort of Myasthenia Gravis Patients in Argentina","volume":"97","author":"Justo","year":"2021","journal-title":"Photochem. Photobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00198-017-4041-0","article-title":"Association between Bone Mineral Density, Muscle Strength, and Vitamin D Status in Patients with Myasthenia Gravis: A Cross-Sectional Study","volume":"28","author":"Guan","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13760-015-0512-2","article-title":"Low Vitamin D Levels in Healthy Controls and Patients with Autoimmune Neuromuscular Disorders in Greece","volume":"116","author":"Chroni","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jocn.2018.01.047","article-title":"Low Serum Vitamin D Levels in Patients with Myasthenia Gravis","volume":"50","author":"Kang","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lipe, D.N., Qdaisat, A., Krishnamani, P.P., Nguyen, T.D., Chaftari, P., El Messiri, N., Srinivasan, A., Galvis-Carvajal, E., Reyes-Gibby, C.C., and Wattana, M.K. (2024). Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review. Diagnostics, 14.","DOI":"10.3390\/diagnostics14161794"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Wang, B., Hao, Y., and Zhu, R. (2023). Clinical Features of Myasthenia Gravis with Neurological and Systemic Autoimmune Diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1223322"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10072-024-07675-6","article-title":"AChR-Seropositive Myasthenia Gravis in Muscular Dystrophy: Diagnostic Pitfalls and Clinical Management Challenges","volume":"46","author":"Avallone","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bareja, N., Chionatos, R.A., Valhuerdi Porto, C., Srinivasan, N., and Ghasemi, M. (2025). Adult-Onset Episodic Rhabdomyolysis in a Patient With a Heterozygous Lipin 1 (LPIN1) Mutation: A Case Report. Cureus.","DOI":"10.7759\/cureus.76772"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10317","DOI":"10.1038\/s41467-024-54097-1","article-title":"Myasthenia Gravis Following Statin Therapy: Evidence from Target Trial Emulation and Self-Controlled Case Series Study","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/CON.0000000000000415","article-title":"Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome","volume":"22","author":"Nicolle","year":"2016","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki, A., Barohn, R.J., Ernstoff, R.M., Kaminski, H.J., Keesey, J.C., Penn, A.S., and Sanders, D.B. (2000). Myasthenia Gravis: Recommendations for Clinical Research Standards. Neurology, 55, 16\u201323.","DOI":"10.1212\/WNL.55.1.16"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups: A Methodology Report","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","article-title":"Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis","volume":"66","author":"Suzuki","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/039463200401700320","article-title":"Association of Myasthenia Gravis and Antisynthetase Syndrome: A Case Report","volume":"17","author":"Diaco","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: Classification of Dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"123213","DOI":"10.1016\/j.jns.2024.123213","article-title":"Myositis -Specific and -Associated Antibodies in Neurological Disorders\u2014A Retrospective Study of 727 Patients","volume":"466","author":"Kleiser","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.jtauto.2022.100148","article-title":"Positioning of Myositis-Specific and Associated Autoantibody (MSA\/MAA) Testing in Disease Criteria and Routine Diagnostic Work-Up","volume":"5","author":"Bonroy","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The Reliability of Immunoassays to Detect Autoantibodies in Patients with Myositis Is Dependent on Autoantibody Specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/annrheumdis-2017-212915","article-title":"Detection of Myositis-Specific Antibodies","volume":"78","author":"Vulsteke","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic Performance of a Commercial Immunoblot Assay for Myositis Antibody Testing","volume":"48","author":"Bundell","year":"2016","journal-title":"Pathology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the Immune System","volume":"59","author":"Aranow","year":"2011","journal-title":"J. Investig. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12026-022-09349-x","article-title":"Vitamin D Receptor Gene Polymorphisms Are Associated with the Risk and Features of Myasthenia Gravis in the Han Chinese Population","volume":"71","author":"Dai","year":"2023","journal-title":"Immunol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2174\/1871527321666220707111344","article-title":"Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Reviewand Meta-Analysis","volume":"22","author":"Bonaccorso","year":"2023","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fan, Y., Huang, H., Chen, X., Chen, Y., Zeng, X., Lin, F., and Chen, X. (2023). Causal Effect of Vitamin D on Myasthenia Gravis: A Two-Sample Mendelian Randomization Study. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1171830"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:09:29Z","timestamp":1760029769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14072449"],"URL":"https:\/\/doi.org\/10.3390\/jcm14072449","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}